A comparative study of renal dysfunction in patients with inflammatory arthropathies: Strong association with cardiovascular diseases and not with anti-rheumatic therapies, inflammatory markers or duration of arthritis

International Journal of Rheumatic Diseases

Volumn 14, Issue 3, 2011, Pages 255-260

  Haroon, Muhammad ^a   Adeeb, Fahd ^a   Devlin, Joe ^a   O'Gradaigh, Donncha ^a   Walker, Frank ^a  

^a WATERFORD REGIONAL HOSPITAL   (Ireland)

Author keywords

Anti rheumatic drugs; Cardiovascular diseases; Chronic kidney disease; Inflammatory arthritis

Indexed keywords

C REACTIVE PROTEIN; CORTICOSTEROID; DISEASE MODIFYING ANTIRHEUMATIC DRUG; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; TUMOR NECROSIS FACTOR INHIBITOR;

ADULT; AGE; AGED; ALBUMINURIA; ARTHRITIS; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE MARKER; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYARTHRITIS; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEINURIA; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS; UNDIFFERENTIATED OLIGOARTHRITIS;

ANTIRHEUMATIC AGENTS; ARTHRITIS; ARTHRITIS, PSORIATIC; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; COHORT STUDIES; COMORBIDITY; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; IRELAND; MALE; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC;

EID: 79961165302     PISSN: 17561841     EISSN: 1756185X     Source Type: Journal    
DOI: 10.1111/j.1756-185X.2011.01594.x     Document Type: Article

References (22)

1. Koseki Y, Terai C, Moriguchi M, et al. (2001) A prospective study of renal disease in patients with early rheumatoid arthritis. Ann Rheum Dis 60, 327-31.
2. Korpela M (1993) Rheumatoid Arthritis and the Kidneys-A Crosssectional Study On Prevalence, Clinical Significance and Risk of Renal and Urinary Tract Diseases in Patients with Rheumatoid Arthritis. Publications of the Social Insurance Institution ML:122, Helsinki.
3. Boers M, Dijkmans BAC, Breedenveld FC, et al. (1990) Subclinical renal dysfunction in rheumatoid arthritis. Arthritis Rheum 33, 95-101.
4. Laasko M, Mutru O, Isomaki H, Koota K (1986) Mortality from amyloidosis and renal disease in patients with rheumatoid arthritis. Ann Rheum Dis 45, 663-7.
5. Boers M, Croonen AM, Dijkmans BA, et al. (1987) Renal findings in rheumatoid arthritis: clinical aspects of 132 necropsies. Ann Rheum Dis 46, 658-63.
6. Adu D, Tse WY (2001) Rheumatoid arthritis, mixed connective tissue disease, and polymyositis. In: Adu D, Emery P, Madaio MP (eds) Rheumatology and the Kidney, pp 293-302. Oxford University Press, New York.
7. Glynn LG, Reddan D, Hayes L, Stack A, Casserly L, Mellotte G (2007) Guidelines on chronic kidney disease. Forum 24, 60-2.
8. McClellan WM, Knight DF, Karp H, Brown WW (1997) Early detection and treatment of renal disease in hospitalized diabetic and hypertensive patients: important differences between practice and published guidelines. Am J Kidney Dis 29, 368-75.
9. Kraft SK, Lazaridis EN, Qiu C, Clark CM Jr, Marrero DG (1999) Screening and treatment of diabetic nephropathy by primary care physicians. J Gen Intern Med 14, 88-97.
10. Wong T, Foote EF, Lefavour GS, Cody RP, Brown CJ, Sherman RA (1999) Physician knowledge and practice patterns relating to diabetic nephropathy. J Am Pharm Assoc (Wash) 39, 785-90.
11. Levey AS (1990) Measurement of renal function in chronic renal disease. Kidney Int 38, 167-84.
12. de Lusignan S, Chan T, Stevens P, et al. (2005) Identifying patients with chronic kidney disease from general practice computer records. Fam Pract 22, 234-41.
13. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS (2003) Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 41, 1-12.
14. Alenius GM, Stegmayr BG, Dahlgvist SR (2001) Renal abnormalities in a population of patients with psoriatic arthritis. Scand J Rheumatol 30, 271-4.
15. Bressolle F, Bologna C, Kinowski JM, Sany J, Combe B (1998) Effects of moderate renal insufficiency on pharmacokinetics of methotrexate in rheumatoid arthritis patients. Ann Rheum Dis 57, 110-3.
16. Bannwarth B, Péhourcq F, Schaeverbeke T, Dehais J (1996; Mar) Clinical pharmacokinetics of low-dose pulse methotrexate in rheumatoid arthritis. Clin Pharmacokinet 30 (3), 194-210.
17. Swedko PJ, Clark HD, Paramsothy K, Akbari A (2003) Serum creatinine is an inadequate screening test for renal failure in elderly patients. Arch Intern Med 163, 356-60.
18. Smith HW (1951) Diseases of the kidney and urinary tract. In: Smith HW (eds) The Kidney: Structure and Function in Health and Disease, pp 836-87. Oxford University Press, New York.
19. Bateman J, Penfold R, Rigby SP (2008; Aug) Comment on: kidney disease in RA patients: prevalence and implication on RA-related drugs management: the MATRIX study. Rheumatology (Oxford) 47 (8), 1259.
20. Daoussis D, Panoulas VF, Antonopoulos I, et al. (2010; Mar) Cardiovascular risk factors and not disease activity, severity or therapy associate with renal dysfunction in patients with rheumatoid arthritis. Ann Rheum Dis 69 (3), 517-21.
21. Stuveling EM, Hillege HL, Bakker SJ, Gans RO, De Jong PE, De Zeeuw D (2003; Feb) C-reactive protein is associated with renal function abnormalities in a non-diabetic population. Kidney Int 63 (2), 654-61.
22. Owen WF, Lowrie EG (1998) C-reactive protein as an outcome predictor for maintenance hemodialysis patients. Kidney Int 54, 627-36.